About us

Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics. Today, Pelago Bioscience is a Drug Discovery Research Partner supporting preclinical drug discovery and development with our expertise in biologically relevant assay systems. Our unique core technology: the Cellular Thermal Shift Assay (CETSA® by Pelago Bioscience) has multiple assay formats that make it a keystone of decision-making throughout the drug discovery pipeline. We offer a range of customized services, from confirming target engagement to strengthening target validation and understanding the mechanism of action of your compounds. Our approach is designed to help you make better decisions faster, no matter where you are in the drug discovery process.

 

Find out more about the Pelago services here.

The Pelago Bioscience Team

Veerle Paternoster

Senior Scientist

Tove Boström

Senior Scientist

Tomas Friman

Senior Scientist

Stina Lundgren

Head of Commercial Operations

Sean Tyacke

CCO

Sarah Sandoz

Operations Manager

Rikard Alm

Senior Scientist

Renato Alves

Project Advisor

Michael Dabrowski

CEO

Marie Karlsson

Scientist

Johan Karlsson

Finance Manager

Jakub Lewicki

Key Account Manager